Invention and validation of highly sensitive immunochromatographic assay for clinical identification of Mycobacterium tuberculosis complex and Non-tuberculous mycobacteria infections
1. To Invent and validate highly sensitive immunochromatographic assay for clinical identification of Mycobacterium tuberculosis complex and Non-tuberculous mycobacteria infections
2. To establish technology transfer and commercialization system based on a WIN-WIN situation between inventors and private sectors.